The NWBO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NWBO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NWBO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View NWBO Detailed Price Forecast - CNN Money||View NWBO Detailed Summary - Google Finance|
|View NWBO Detailed Summary - Yahoo! Finance||View NWBO Stock Research & Analysis - Zacks.com|
|View NWBO Trends & Analysis - Trade-Ideas||View NWBO Major Holders - Barrons|
|View NWBO Call Transcripts - NASDAQ||View NWBO Breaking News & Analysis - Seeking Alpha|
|View NWBO Annual Report - CompanySpotlight.com||View NWBO OTC Short Report - OTCShortReport.com|
|View NWBO Fundamentals - TradeKing||View NWBO SEC Filings - Bar Chart|
|View Historical Prices for NWBO - The WSJ||View Performance/Total Return for NWBO - Morningstar|
|View the Analyst Estimates for NWBO - MarketWatch||View the Earnings History for NWBO - CNBC|
|View the NWBO Earnings - StockMarketWatch||View NWBO Buy or Sell Recommendations - MacroAxis|
|View the NWBO Bullish Patterns - American Bulls||View NWBO Short Pain Metrics - ShortPainBot.com|
|View NWBO Stock Mentions - StockTwits||View NWBO Stock Mentions - PennyStockTweets|
|View NWBO Stock Mentions - Twitter||View NWBO Investment Forum News - Investor Hub|
|View NWBO Stock Mentions - Yahoo! Message Board||View NWBO Stock Mentions - Seeking Alpha|
|View Insider Transactions for NWBO - SECform4.com||View Insider Transactions for NWBO - Insider Cow|
|View NWBO Major Holdings Summary - CNBC||View Insider Disclosure for NWBO - OTC Markets|
|View Insider Transactions for NWBO - Yahoo! Finance||View Institutional Holdings for NWBO - NASDAQ|
|View NWBO Stock Insight & Charts - FinViz.com||View NWBO Investment Charts - StockCharts.com|
|View NWBO Stock Overview & Charts - BarChart||View NWBO User Generated Charts - Trading View|
Northwest Biotherapeutics: 1Q Earnings Snapshot
Posted on Thursday May 17, 2018
The Bethesda, Maryland-based company said it had a loss of 9 cents per share. Losses, adjusted for one-time gains and costs, came to 6 cents per share. The cancer drug developer posted revenue of $132,000 ...
NW Bio Releases Vote Tallies From Special Shareholder Meeting
Posted on Tuesday May 01, 2018
BETHESDA, Md., May 1, 2018 /PRNewswire/ -- Northwest Biotherapeutics (NWBO) -- ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today released the vote tallies for the three proposals on the ballot at its Special Meeting of Shareholders held last Friday afternoon in Washington, DC. Proposal 1 was to raise the ceiling on the total number of authorized shares of common stock of the Company from 450 million to 1.2 billion. For this Proposal, only the common shares could vote. This Proposal was approved, with Yes votes from 87% of the votes cast (245,267,573), with 4% voting against (11,699,346), and 9% abstaining (25,836,335 votes). 30% did not vote (131,861,943). Proposal 2 was to raise the ceiling on the total number of authorized shares of preferred stock of the Company from 40 million to 100 million. For this Proposal, both the preferred stock and the common stock could vote. This Proposal was approved with Yes votes from 86% of the votes cast (327,025,901), with 7% voting against (27,266,121), and 7% abstaining (25,796,199).
NW Bio Announces Additional Funding
Posted on Monday April 30, 2018
On April 26, 2018, the Company and Ms. Powers entered into a note and loan agreement for an additional loan of $1.0 million by Ms. Powers to the Company on the same terms as her prior funding, as previously reported in March. The Note is convertible into Series B Preferred Stock at $2.30 per share (with each share of Series B Preferred Stock convertible into ten shares of Common Stock at $0.23 per share), and Class D-2 Warrants exercisable for an equal number of shares of Common Stock at $0.30 per share, with warrants on half of the Note repayment amount due and issuable when the loan was provided, and warrants on half of the Note repayment amount due on a proportional basis in the event of conversion of some or all of the Note.
Independent Research on Trending Growth Companies: Northwest Biotherapeutics and Sanuwave Health
Posted on Monday February 26, 2018
NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Northwest Biotherapeutics, Inc. (OTCQB: NWBO) and Sanuwave Health ...